nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—chronic obstructive pulmonary disease	0.568	1	CbGaD
Alitretinoin—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.00926	0.529	CbGbCtD
Alitretinoin—CRABP1—connective tissue—chronic obstructive pulmonary disease	0.00478	0.082	CbGeAlD
Alitretinoin—CRABP1—bronchus—chronic obstructive pulmonary disease	0.00447	0.0766	CbGeAlD
Alitretinoin—RARB—respiratory system—chronic obstructive pulmonary disease	0.0044	0.0753	CbGeAlD
Alitretinoin—CRABP2—connective tissue—chronic obstructive pulmonary disease	0.00433	0.0741	CbGeAlD
Alitretinoin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00423	0.242	CbGbCtD
Alitretinoin—CRABP2—bronchus—chronic obstructive pulmonary disease	0.00404	0.0693	CbGeAlD
Alitretinoin—CRABP1—trachea—chronic obstructive pulmonary disease	0.00402	0.0688	CbGeAlD
Alitretinoin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.004	0.229	CbGbCtD
Alitretinoin—CRABP2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00396	0.0678	CbGeAlD
Alitretinoin—CRABP2—trachea—chronic obstructive pulmonary disease	0.00363	0.0622	CbGeAlD
Alitretinoin—RARB—bronchus—chronic obstructive pulmonary disease	0.00362	0.062	CbGeAlD
Alitretinoin—RARG—respiratory system—chronic obstructive pulmonary disease	0.00359	0.0614	CbGeAlD
Alitretinoin—RARA—respiratory system—chronic obstructive pulmonary disease	0.00337	0.0578	CbGeAlD
Alitretinoin—CRABP2—lung—chronic obstructive pulmonary disease	0.00261	0.0447	CbGeAlD
Alitretinoin—RARB—lung—chronic obstructive pulmonary disease	0.00233	0.04	CbGeAlD
Alitretinoin—RXRB—lung—chronic obstructive pulmonary disease	0.00214	0.0368	CbGeAlD
Alitretinoin—RARG—lung—chronic obstructive pulmonary disease	0.0019	0.0326	CbGeAlD
Alitretinoin—RARA—lung—chronic obstructive pulmonary disease	0.00179	0.0307	CbGeAlD
Alitretinoin—Vitamin A—CYP1A1—chronic obstructive pulmonary disease	0.00125	0.362	CrCbGaD
Alitretinoin—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00125	0.0214	CbGeAlD
Alitretinoin—Tretinoin—CYP1A1—chronic obstructive pulmonary disease	0.00121	0.35	CrCbGaD
Alitretinoin—Acitretin—ALB—chronic obstructive pulmonary disease	0.000996	0.288	CrCbGaD
Alitretinoin—CYP1A2—lung—chronic obstructive pulmonary disease	0.000664	0.0114	CbGeAlD
Alitretinoin—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00064	0.011	CbGeAlD
Alitretinoin—ABCB1—trachea—chronic obstructive pulmonary disease	0.000473	0.00811	CbGeAlD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.00039	0.0049	CbGpPWpGaD
Alitretinoin—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.000384	0.00483	CbGpPWpGaD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000383	0.00481	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000366	0.00459	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000353	0.00443	CbGpPWpGaD
Alitretinoin—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000352	0.00442	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000348	0.00437	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000345	0.00433	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000344	0.00432	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.000343	0.00431	CbGpPWpGaD
Alitretinoin—ABCB1—lung—chronic obstructive pulmonary disease	0.00034	0.00583	CbGeAlD
Alitretinoin—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000338	0.00425	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000337	0.00423	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000332	0.00417	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—chronic obstructive pulmonary disease	0.000322	0.00404	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00032	0.00402	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000313	0.00393	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000313	0.00393	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000311	0.0039	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00031	0.00389	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000308	0.00387	CbGpPWpGaD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—chronic obstructive pulmonary disease	0.0003	0.00377	CbGpPWpGaD
Alitretinoin—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000294	0.0037	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000292	0.00367	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000291	0.00365	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000291	0.00365	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000288	0.00362	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.00362	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000288	0.00362	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000287	0.00361	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000286	0.0036	CbGpPWpGaD
Alitretinoin—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00356	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GC—chronic obstructive pulmonary disease	0.000283	0.00355	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GC—chronic obstructive pulmonary disease	0.000283	0.00355	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	0.00028	0.00352	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000277	0.00348	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000273	0.00343	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.000272	0.00342	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00027	0.00339	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.00027	0.00339	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000263	0.0033	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000263	0.0033	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000251	0.00316	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000248	0.00311	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000238	0.00299	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00296	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000233	0.00293	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000231	0.0029	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00023	0.00289	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.00285	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000225	0.00283	CbGpPWpGaD
Alitretinoin—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000219	0.00275	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000216	0.00271	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000216	0.00271	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000216	0.00271	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000213	0.00268	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00263	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00263	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000207	0.0026	CbGpPWpGaD
Alitretinoin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000207	0.000759	CcSEcCtD
Alitretinoin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.000758	CcSEcCtD
Alitretinoin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000207	0.000758	CcSEcCtD
Alitretinoin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.000755	CcSEcCtD
Alitretinoin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.000751	CcSEcCtD
Alitretinoin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000204	0.000749	CcSEcCtD
Alitretinoin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000204	0.000748	CcSEcCtD
Alitretinoin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.000748	CcSEcCtD
Alitretinoin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000204	0.000747	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.000203	0.00255	CbGpPWpGaD
Alitretinoin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000202	0.000742	CcSEcCtD
Alitretinoin—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000739	CcSEcCtD
Alitretinoin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000736	CcSEcCtD
Alitretinoin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.000736	CcSEcCtD
Alitretinoin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000732	CcSEcCtD
Alitretinoin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000729	CcSEcCtD
Alitretinoin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000729	CcSEcCtD
Alitretinoin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000728	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000198	0.00249	CbGpPWpGaD
Alitretinoin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.000725	CcSEcCtD
Alitretinoin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.000725	CcSEcCtD
Alitretinoin—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000724	CcSEcCtD
Alitretinoin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000722	CcSEcCtD
Alitretinoin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000719	CcSEcCtD
Alitretinoin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000718	CcSEcCtD
Alitretinoin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.000715	CcSEcCtD
Alitretinoin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.000712	CcSEcCtD
Alitretinoin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.000712	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000711	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000711	CcSEcCtD
Alitretinoin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000192	0.000705	CcSEcCtD
Alitretinoin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.000705	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000192	0.00241	CbGpPWpGaD
Alitretinoin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000702	CcSEcCtD
Alitretinoin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000191	0.000701	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000191	0.0024	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00019	0.000696	CcSEcCtD
Alitretinoin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.000695	CcSEcCtD
Alitretinoin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00019	0.000695	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000189	0.00238	CbGpPWpGaD
Alitretinoin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.000693	CcSEcCtD
Alitretinoin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000189	0.000693	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000189	0.00237	CbGpPWpGaD
Alitretinoin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000189	0.000691	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000689	CcSEcCtD
Alitretinoin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000688	CcSEcCtD
Alitretinoin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000687	CcSEcCtD
Alitretinoin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000687	CcSEcCtD
Alitretinoin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000187	0.000686	CcSEcCtD
Alitretinoin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.000684	CcSEcCtD
Alitretinoin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000185	0.000679	CcSEcCtD
Alitretinoin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000185	0.000678	CcSEcCtD
Alitretinoin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000676	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000673	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000673	CcSEcCtD
Alitretinoin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.000672	CcSEcCtD
Alitretinoin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000183	0.000672	CcSEcCtD
Alitretinoin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.000672	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000671	CcSEcCtD
Alitretinoin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000667	CcSEcCtD
Alitretinoin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000667	CcSEcCtD
Alitretinoin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000667	CcSEcCtD
Alitretinoin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000667	CcSEcCtD
Alitretinoin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000182	0.000666	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000181	0.00228	CbGpPWpGaD
Alitretinoin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000661	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000659	CcSEcCtD
Alitretinoin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00018	0.000659	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000179	0.00225	CbGpPWpGaD
Alitretinoin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000657	CcSEcCtD
Alitretinoin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000655	CcSEcCtD
Alitretinoin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000653	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000178	0.000653	CcSEcCtD
Alitretinoin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.000652	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000649	CcSEcCtD
Alitretinoin—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000649	CcSEcCtD
Alitretinoin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000648	CcSEcCtD
Alitretinoin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.000646	CcSEcCtD
Alitretinoin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000176	0.000646	CcSEcCtD
Alitretinoin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000644	CcSEcCtD
Alitretinoin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.000643	CcSEcCtD
Alitretinoin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000175	0.000643	CcSEcCtD
Alitretinoin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.000642	CcSEcCtD
Alitretinoin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.00064	CcSEcCtD
Alitretinoin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00064	CcSEcCtD
Alitretinoin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.000639	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000174	0.00219	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.000638	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000174	0.000638	CcSEcCtD
Alitretinoin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000637	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.000636	CcSEcCtD
Alitretinoin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.000635	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000172	0.00216	CbGpPWpGaD
Alitretinoin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00063	CcSEcCtD
Alitretinoin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00063	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00017	0.000625	CcSEcCtD
Alitretinoin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000624	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000624	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.00017	0.00214	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000169	0.00213	CbGpPWpGaD
Alitretinoin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00062	CcSEcCtD
Alitretinoin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00062	CcSEcCtD
Alitretinoin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000617	CcSEcCtD
Alitretinoin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000168	0.000617	CcSEcCtD
Alitretinoin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000617	CcSEcCtD
Alitretinoin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.000617	CcSEcCtD
Alitretinoin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000615	CcSEcCtD
Alitretinoin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.000614	CcSEcCtD
Alitretinoin—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00061	CcSEcCtD
Alitretinoin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.000609	CcSEcCtD
Alitretinoin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000166	0.000609	CcSEcCtD
Alitretinoin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.000609	CcSEcCtD
Alitretinoin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000166	0.000607	CcSEcCtD
Alitretinoin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000607	CcSEcCtD
Alitretinoin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000165	0.000605	CcSEcCtD
Alitretinoin—RXRA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00207	CbGpPWpGaD
Alitretinoin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000604	CcSEcCtD
Alitretinoin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000165	0.000604	CcSEcCtD
Alitretinoin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000603	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000602	CcSEcCtD
Alitretinoin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000163	0.000598	CcSEcCtD
Alitretinoin—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000596	CcSEcCtD
Alitretinoin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.000595	CcSEcCtD
Alitretinoin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000594	CcSEcCtD
Alitretinoin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000592	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000161	0.00202	CbGpPWpGaD
Alitretinoin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.000585	CcSEcCtD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000159	0.002	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000159	0.002	CbGpPWpGaD
Alitretinoin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000582	CcSEcCtD
Alitretinoin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.000582	CcSEcCtD
Alitretinoin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000157	0.000575	CcSEcCtD
Alitretinoin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.000575	CcSEcCtD
Alitretinoin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.000574	CcSEcCtD
Alitretinoin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000573	CcSEcCtD
Alitretinoin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000572	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000154	0.00194	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000154	0.00194	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000154	0.000563	CcSEcCtD
Alitretinoin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00056	CcSEcCtD
Alitretinoin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00056	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000153	0.00192	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000153	0.00192	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000151	0.0019	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.0019	CbGpPWpGaD
Alitretinoin—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.0019	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.0019	CbGpPWpGaD
Alitretinoin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000151	0.000552	CcSEcCtD
Alitretinoin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.000552	CcSEcCtD
Alitretinoin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000548	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000149	0.00187	CbGpPWpGaD
Alitretinoin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000148	0.000543	CcSEcCtD
Alitretinoin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000543	CcSEcCtD
Alitretinoin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00054	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000147	0.00185	CbGpPWpGaD
Alitretinoin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.000534	CcSEcCtD
Alitretinoin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000146	0.000534	CcSEcCtD
Alitretinoin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000531	CcSEcCtD
Alitretinoin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000529	CcSEcCtD
Alitretinoin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000528	CcSEcCtD
Alitretinoin—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000526	CcSEcCtD
Alitretinoin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000143	0.000523	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000142	0.00179	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000142	0.00179	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000142	0.00179	CbGpPWpGaD
Alitretinoin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.000521	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000141	0.00178	CbGpPWpGaD
Alitretinoin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000141	0.000518	CcSEcCtD
Alitretinoin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.000516	CcSEcCtD
Alitretinoin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000141	0.000516	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000141	0.00177	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000139	0.00175	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000139	0.00175	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000139	0.00175	CbGpPWpGaD
Alitretinoin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000505	CcSEcCtD
Alitretinoin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000505	CcSEcCtD
Alitretinoin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.000504	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000137	0.00172	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000136	0.00171	CbGpPWpGaD
Alitretinoin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000496	CcSEcCtD
Alitretinoin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000496	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000135	0.0017	CbGpPWpGaD
Alitretinoin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000492	CcSEcCtD
Alitretinoin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000492	CcSEcCtD
Alitretinoin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.000491	CcSEcCtD
Alitretinoin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000134	0.000491	CcSEcCtD
Alitretinoin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000491	CcSEcCtD
Alitretinoin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.000489	CcSEcCtD
Alitretinoin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000133	0.000489	CcSEcCtD
Alitretinoin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000488	CcSEcCtD
Alitretinoin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.000488	CcSEcCtD
Alitretinoin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000487	CcSEcCtD
Alitretinoin—RXRA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000133	0.00167	CbGpPWpGaD
Alitretinoin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000486	CcSEcCtD
Alitretinoin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000482	CcSEcCtD
Alitretinoin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000481	CcSEcCtD
Alitretinoin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00048	CcSEcCtD
Alitretinoin—Depression—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00048	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000131	0.00164	CbGpPWpGaD
Alitretinoin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000131	0.000479	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.00013	0.00163	CbGpPWpGaD
Alitretinoin—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000474	CcSEcCtD
Alitretinoin—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000472	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000472	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000128	0.00161	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00161	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00161	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000128	0.00161	CbGpPWpGaD
Alitretinoin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000468	CcSEcCtD
Alitretinoin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000467	CcSEcCtD
Alitretinoin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000464	CcSEcCtD
Alitretinoin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000464	CcSEcCtD
Alitretinoin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000464	CcSEcCtD
Alitretinoin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000463	CcSEcCtD
Alitretinoin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000463	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.000126	0.00158	CbGpPWpGaD
Alitretinoin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.000461	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000125	0.00157	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000455	CcSEcCtD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000124	0.00156	CbGpPWpGaD
Alitretinoin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000454	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000123	0.00155	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000123	0.00154	CbGpPWpGaD
Alitretinoin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000448	CcSEcCtD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00154	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000122	0.00153	CbGpPWpGaD
Alitretinoin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000447	CcSEcCtD
Alitretinoin—RARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000121	0.00152	CbGpPWpGaD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.00152	CbGpPWpGaD
Alitretinoin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000437	CcSEcCtD
Alitretinoin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000435	CcSEcCtD
Alitretinoin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000434	CcSEcCtD
Alitretinoin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000118	0.000432	CcSEcCtD
Alitretinoin—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00043	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000117	0.00147	CbGpPWpGaD
Alitretinoin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000422	CcSEcCtD
Alitretinoin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000422	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000115	0.00144	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000115	0.00144	CbGpPWpGaD
Alitretinoin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000416	CcSEcCtD
Alitretinoin—RARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000113	0.00142	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000113	0.00141	CbGpPWpGaD
Alitretinoin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000412	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000408	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000111	0.00139	CbGpPWpGaD
Alitretinoin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000404	CcSEcCtD
Alitretinoin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000401	CcSEcCtD
Alitretinoin—RARB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000109	0.00136	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000108	0.00135	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000107	0.00134	CbGpPWpGaD
Alitretinoin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000392	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000106	0.00133	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000106	0.00133	CbGpPWpGaD
Alitretinoin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000386	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000105	0.00132	CbGpPWpGaD
Alitretinoin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000382	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000382	CcSEcCtD
Alitretinoin—RARA—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000104	0.00131	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000104	0.00131	CbGpPWpGaD
Alitretinoin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000379	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000103	0.0013	CbGpPWpGaD
Alitretinoin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000378	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000103	0.0013	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000103	0.00129	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.00129	CbGpPWpGaD
Alitretinoin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000376	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000376	CcSEcCtD
Alitretinoin—RARB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000101	0.00127	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	9.92e-05	0.00125	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.91e-05	0.00125	CbGpPWpGaD
Alitretinoin—Pain—Prednisolone—chronic obstructive pulmonary disease	9.86e-05	0.000361	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.85e-05	0.00124	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.85e-05	0.00124	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.84e-05	0.00124	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.84e-05	0.00124	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.69e-05	0.00122	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.69e-05	0.00122	CbGpPWpGaD
Alitretinoin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.67e-05	0.000354	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	9.67e-05	0.00121	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000349	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.5e-05	0.000348	CcSEcCtD
Alitretinoin—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	9.49e-05	0.00119	CbGpPWpGaD
Alitretinoin—Anaemia—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000348	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.47e-05	0.00119	CbGpPWpGaD
Alitretinoin—Agitation—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.000346	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.32e-05	0.00117	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.32e-05	0.00117	CbGpPWpGaD
Alitretinoin—Malaise—Prednisone—chronic obstructive pulmonary disease	9.25e-05	0.000339	CcSEcCtD
Alitretinoin—Syncope—Prednisone—chronic obstructive pulmonary disease	9.2e-05	0.000337	CcSEcCtD
Alitretinoin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.000336	CcSEcCtD
Alitretinoin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000331	CcSEcCtD
Alitretinoin—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.89e-05	0.000326	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	8.88e-05	0.00112	CbGpPWpGaD
Alitretinoin—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000325	CcSEcCtD
Alitretinoin—RXRA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.8e-05	0.0011	CbGpPWpGaD
Alitretinoin—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.00032	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.00032	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	8.72e-05	0.0011	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.72e-05	0.0011	CbGpPWpGaD
Alitretinoin—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000319	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000318	CcSEcCtD
Alitretinoin—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000316	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.62e-05	0.00108	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GC—chronic obstructive pulmonary disease	8.56e-05	0.00107	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.49e-05	0.000311	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000307	CcSEcCtD
Alitretinoin—Oedema—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000307	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.37e-05	0.00105	CbGpPWpGaD
Alitretinoin—Infection—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.000305	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—TNF—chronic obstructive pulmonary disease	8.29e-05	0.00104	CbGpPWpGaD
Alitretinoin—Shock—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000302	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.21e-05	0.000301	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.17e-05	0.0003	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000298	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.1e-05	0.000297	CcSEcCtD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	8.09e-05	0.00102	CbGpPWpGaD
Alitretinoin—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000293	CcSEcCtD
Alitretinoin—RXRA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.95e-05	0.000999	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.00028	CcSEcCtD
Alitretinoin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.62e-05	0.000279	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000278	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000276	CcSEcCtD
Alitretinoin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.37e-05	0.00027	CcSEcCtD
Alitretinoin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.28e-05	0.000267	CcSEcCtD
Alitretinoin—Rash—Prednisolone—chronic obstructive pulmonary disease	7.27e-05	0.000266	CcSEcCtD
Alitretinoin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.26e-05	0.000266	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000265	CcSEcCtD
Alitretinoin—Headache—Prednisolone—chronic obstructive pulmonary disease	7.22e-05	0.000265	CcSEcCtD
Alitretinoin—Constipation—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000262	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	7.11e-05	0.000893	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	7.09e-05	0.000891	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.08e-05	0.00089	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000253	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000251	CcSEcCtD
Alitretinoin—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.85e-05	0.000251	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.82e-05	0.000857	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	6.8e-05	0.000854	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—chronic obstructive pulmonary disease	6.69e-05	0.00084	CbGpPWpGaD
Alitretinoin—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.65e-05	0.000244	CcSEcCtD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	6.65e-05	0.000835	CbGpPWpGaD
Alitretinoin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000243	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000243	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	6.53e-05	0.00082	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.5e-05	0.000817	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	6.4e-05	0.000804	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.38e-05	0.000801	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.38e-05	0.000801	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—chronic obstructive pulmonary disease	6.34e-05	0.000796	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—chronic obstructive pulmonary disease	6.34e-05	0.000796	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.34e-05	0.000796	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.17e-05	0.000226	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—LEP—chronic obstructive pulmonary disease	6.16e-05	0.000774	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.13e-05	0.00077	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	6.09e-05	0.000765	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.07e-05	0.000763	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.07e-05	0.000763	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.06e-05	0.000762	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.06e-05	0.000762	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.04e-05	0.000759	CbGpPWpGaD
Alitretinoin—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.00022	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.96e-05	0.000749	CbGpPWpGaD
Alitretinoin—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000217	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	5.76e-05	0.000723	CbGpPWpGaD
Alitretinoin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.73e-05	0.00021	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.55e-05	0.000698	CbGpPWpGaD
Alitretinoin—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000203	CcSEcCtD
Alitretinoin—RARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.52e-05	0.000693	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.48e-05	0.000688	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CTGF—chronic obstructive pulmonary disease	5.42e-05	0.000681	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	5.37e-05	0.000675	CbGpPWpGaD
Alitretinoin—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.32e-05	0.000195	CcSEcCtD
Alitretinoin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	5.31e-05	0.000667	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	5.28e-05	0.000664	CbGpPWpGaD
Alitretinoin—Rash—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000194	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.28e-05	0.000193	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.27e-05	0.000661	CbGpPWpGaD
Alitretinoin—Headache—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.000192	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.19e-05	0.000652	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	5.13e-05	0.000645	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HDAC2—chronic obstructive pulmonary disease	5.05e-05	0.000635	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.05e-05	0.000634	CbGpPWpGaD
Alitretinoin—Nausea—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000182	CcSEcCtD
Alitretinoin—RARB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.95e-05	0.000622	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	4.93e-05	0.00062	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.74e-05	0.000596	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.74e-05	0.000596	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.67e-05	0.000587	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCLC—chronic obstructive pulmonary disease	4.62e-05	0.00058	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.31e-05	0.000541	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.24e-05	0.000532	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CTGF—chronic obstructive pulmonary disease	4.22e-05	0.00053	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.1e-05	0.000515	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.88e-05	0.000488	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.7e-05	0.000465	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.52e-05	0.000442	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	3.42e-05	0.00043	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.32e-05	0.000418	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.24e-05	0.000407	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.2e-05	0.000401	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.18e-05	0.000399	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.05e-05	0.000383	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.02e-05	0.000379	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.99e-05	0.000376	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.98e-05	0.000374	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.85e-05	0.000358	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.84e-05	0.000357	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000355	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-05	0.000353	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	2.73e-05	0.000343	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.73e-05	0.000342	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.61e-05	0.000328	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.56e-05	0.000321	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-05	0.000319	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.47e-05	0.000311	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.44e-05	0.000306	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000289	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.15e-05	0.00027	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.000254	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000241	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.87e-05	0.000235	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.85e-05	0.000232	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000231	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.68e-05	0.000212	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.64e-05	0.000206	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.55e-05	0.000195	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.000187	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.47e-05	0.000185	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000173	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000169	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.29e-05	0.000163	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.00016	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.19e-05	0.000149	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.13e-05	0.000142	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.00013	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.000128	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.5e-06	0.000119	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9e-06	0.000113	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	7.67e-06	9.63e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.33e-06	9.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.12e-06	7.69e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.85e-06	7.36e-05	CbGpPWpGaD
